Cinemark Holdings Toekomstige groei
Future criteriumcontroles 2/6
Cinemark Holdings zal naar verwachting groeien in winst en omzet met respectievelijk 10.8% en 4.8% per jaar. De winst per aandeel zal naar verwachting groeien met 13.1% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 39.1% zijn.
Belangrijke informatie
10.8%
Groei van de winst
13.10%
Groei van de winst per aandeel
| Entertainment winstgroei | 23.8% |
| Inkomstengroei | 4.8% |
| Toekomstig rendement op eigen vermogen | 39.11% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 11 Sep 2026 |
Recente toekomstige groei-updates
Geen updates
Recent updates
Narratiefupdate • Sep 17
CNK: Record Summer Box Office And Film Slate Execution Will Drive Future Returns
The analyst fair value estimate for Cinemark Holdings has been adjusted slightly higher to $40.00, with analysts pointing to solid box office execution, margin resilience, and a more mixed but generally constructive set of price target moves as the main drivers of the update. Analyst Commentary Recent Street research on Cinemark Holdings presents a mix of optimism on execution and balance sheet quality alongside more cautious views on the film slate and risk and reward at current levels.
Narratiefupdate • Aug 15
CNK: Future Returns Will Hinge On Film Slate Consistency Risk
The analyst fair value estimate for Cinemark Holdings has been revised higher from $31.13 to $33.00 as analysts factor in updated box office expectations, a modestly lower discount rate, and slightly stronger margin assumptions following a wave of recent price target changes and rating shifts. Analyst Commentary Recent Street research on Cinemark Holdings shows a mixed setup.Narratiefupdate • Jul 31
CNK: Record Q2 Execution And Film Slate Trends Will Shape Future Returns
The analyst price target for Cinemark Holdings in this update moves to $38.36, with analysts pointing to recent Q2 performance, box office recovery trends, and company-specific execution on operations, balance sheet, and margins as key reasons for revisiting their assumptions. Analyst Commentary Recent Street research on Cinemark Holdings shows a mix of optimism and caution, with many firms adjusting price targets after Q1 and Q2 updates.Narratiefupdate • Jul 10
CNK: Strong Box Office Recovery And Margin Execution Will Shape Next Leg
Cinemark Holdings' updated analyst price target of $31.13, up from $26.09, reflects analysts' use of slightly higher revenue growth, profit margin and future P/E assumptions, supported by recent Street research citing improved box office trends, solid execution and a recalibration of industry risks. Analyst Commentary Recent Street research on Cinemark Holdings points to a mixed tone, with some firms becoming more constructive on box office trends and execution, while others highlight that much of the upside case may already be reflected in the stock's valuation.Narratiefupdate • Jun 23
CNK: Box Office Momentum And Margin Assumptions Will Support Future Returns
The analyst price target for Cinemark Holdings has been raised by about $3.40, with analysts attributing the change to a lower required discount rate, slightly higher profit margin assumptions, and supportive recent research that cites stronger Q1 results and improving Q2 box office trends as key factors. Analyst Commentary Recent Street research on Cinemark Holdings points to a cluster of higher price targets, with analysts updating their models after Q1 results and early reads on Q2 box office performance.Narratiefupdate • Jun 05
CNK: Record Box Office Strength Will Limit Future Upside As Margins Tighten
Narrative Update on Cinemark Holdings The analyst price target for Cinemark Holdings has increased by about $0.83. Analysts cite adjusted fair value assumptions, a slightly lower discount rate, refined expectations for revenue growth and profit margins, and updated future P/E assumptions as the key drivers of this change.Narratiefupdate • Apr 21
CNK: 2026 Margin Expansion Assumptions Will Constrain Upside As Box Office Normalizes
The updated analyst price target for Cinemark Holdings rises by about $1.52 to $25.26 as analysts factor in slightly higher revenue growth, a modestly stronger profit margin profile, and a higher assumed future P/E multiple. Analyst Commentary Recent research on Cinemark shows a mix of optimism and restraint, with some firms lifting price targets while others remain cautious on execution and long term growth assumptions.Narratiefupdate • Apr 06
CNK: 2026 Margin Risk As Box Office Normalizes Will Cap Upside
The analyst price target for Cinemark Holdings has been raised, with moves such as B. Riley lifting its target to $30, Roth Capital to $36, and Goldman Sachs to $22, as analysts weigh roughly in line Q4 results, stronger per-capita metrics, and debates around market share, pricing, and margin potential into 2026 and beyond.Narratiefupdate • Mar 23
CNK: 2026 Margin Uncertainty Around Normalized Box Office Will Limit Upside
Analysts have nudged their price targets on Cinemark higher by a few dollars, into a $22 to $36 range. This reflects updated views on box office recovery potential, questions about margin expansion, and recent Q4 performance trends.Narratiefupdate • Mar 08
CNK: Future Box Office Slate And Buybacks Will Support Returns
Analysts have nudged their price targets for Cinemark higher, with a range now stretching from $22 to $36. This reflects updated views on future box office trends, margin potential, and the company’s ability to sustain stronger per capita spending as film supply normalizes.Seeking Alpha • Feb 27
Cinemark: Strongest Performer In A Weak Industry
Summary Cinemark Holdings, Inc. is facing persistent long-term industry headwinds despite potential for near-term box office upside. Unusually, I am more optimistic than industry estimates; thanks to Spider-Man and Avengers, the 2026 box office might just push above $10 billion for the first time since COVID. Concessions revenue now exceeds 80% of admissions, but rising film rental costs and G&A expenses pressured CNK's 2025 operating income. Movie Club subscription shows promise but lacks aggressive management support to materially improve CNK's long-term prospects. Read the full article on Seeking AlphaNarratiefupdate • Feb 22
CNK: 2026 Margin Uncertainty Will Likely Restrain Share Price Potential
Analysts have nudged their average price targets higher for Cinemark, with our fair value estimate moving from $22.50 to $23.74 as they factor in updated box office expectations, ongoing margin discussions for 2026, and mixed but generally constructive recent target revisions across the Street. Analyst Commentary Street research on Cinemark is mixed, with some firms lifting price targets after the latest quarterly update while others stay cautious on execution and long term profitability.Narratiefupdate • Feb 07
CNK: Lower Margin Expectations Will Shape Future Performance
Narrative Update The updated analyst price target for Cinemark Holdings has moved from about US$26.76 to roughly US$22.50, as analysts factor in a slightly lower fair value, modestly reduced profit margin expectations, and a lower assumed future P/E in light of recent price target trims and an upgrade from major research firms. Analyst Commentary Recent Street research has leaned more cautious on Cinemark Holdings, with several firms trimming their price targets and rethinking what they are willing to pay for the stock.Narratiefupdate • Jan 24
CNK: Balance Sheet Progress And Buybacks Will Support Future Shareholder Returns
Narrative Update on Cinemark Holdings Analysts have trimmed their blended price target on Cinemark Holdings by about US$1.27. This reflects recent target cuts from several firms, alongside one upgrade that highlights improved balance sheet flexibility and ongoing expectations around margins, revenue trends, and P/E assumptions.Narratiefupdate • Jan 10
CNK: Increased Financial Flexibility Will Drive Future Capital Returns Potential
Analysts have trimmed their fair value estimate for Cinemark Holdings to about US$33.09 from roughly US$33.91, citing a slightly higher discount rate and P/E assumptions, along with updated views on revenue growth, profit margins, and the company’s increased financial flexibility after paying down pandemic related debt and gaining more room to reinvest, return capital, and consider M&A. Analyst Commentary Bullish Takeaways Bullish analysts point to the recent price target increase to US$35 as a sign that they see upside potential relative to current fair value assumptions, even after slightly higher discount rate and P/E inputs.Analyse-artikel • Jan 03
A Look At The Intrinsic Value Of Cinemark Holdings, Inc. (NYSE:CNK)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Cinemark Holdings fair value estimate is US$29.03 Current...Analyse-artikel • Dec 19
Investors Give Cinemark Holdings, Inc. (NYSE:CNK) Shares A 27% Hiding
Cinemark Holdings, Inc. ( NYSE:CNK ) shares have had a horrible month, losing 27% after a relatively good period...Narratiefupdate • Dec 14
CNK: Box Office Recovery And Capital Returns Will Shape Future Performance
Cinemark Holdings' analyst price target has been raised by $1 to $35 per share, as analysts highlight the company’s strong recent performance, improved profit profile, and greater financial flexibility following pandemic debt reduction. Analyst Commentary While the latest price target increase reflects confidence in Cinemark Holdings' operational progress and balance sheet strength, not all market observers share an unequivocally bullish stance.Analyse-artikel • Oct 06
At US$28.23, Is It Time To Put Cinemark Holdings, Inc. (NYSE:CNK) On Your Watch List?
Cinemark Holdings, Inc. ( NYSE:CNK ), might not be a large cap stock, but it saw a double-digit share price rise of...Analyse-artikel • Sep 04
Does Cinemark Holdings (NYSE:CNK) Have A Healthy Balance Sheet?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analyse-artikel • Jul 25
Is Now The Time To Put Cinemark Holdings (NYSE:CNK) On Your Watchlist?
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Analyse-artikel • Jun 30
Estimating The Intrinsic Value Of Cinemark Holdings, Inc. (NYSE:CNK)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Cinemark Holdings fair value estimate is US$34.64 Cinemark...Analyse-artikel • May 19
Is Cinemark Holdings, Inc. (NYSE:CNK) Potentially Undervalued?
While Cinemark Holdings, Inc. ( NYSE:CNK ) might not have the largest market cap around , it led the NYSE gainers with...Analyse-artikel • May 07
Investors Still Aren't Entirely Convinced By Cinemark Holdings, Inc.'s (NYSE:CNK) Earnings Despite 25% Price Jump
Cinemark Holdings, Inc. ( NYSE:CNK ) shareholders would be excited to see that the share price has had a great month...Analyse-artikel • Apr 27
Is Cinemark Holdings (NYSE:CNK) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Seeking Alpha • Apr 24
Is Cinemark's Stock Rally Due For A Cool-Down?
Summary Cinemark's stock surged last year, but now offers a thin margin of safety; wait for a pullback to the $24-$25 range before investing. Despite a mixed 2024, Cinemark's robust concession sales, premium formats, and loyalty programs drive margins and position it well for a strong rebound in 2025. The stock trades at a premium, but has strong growth-adjusted metrics and potential for upside surprises, making it a mixed but promising investment. Given expected Q1 weakness and current valuation, it's prudent to wait for a more attractive entry point to optimize risk/reward. Read the full article on Seeking AlphaAnalyse-artikel • Mar 31
We Ran A Stock Scan For Earnings Growth And Cinemark Holdings (NYSE:CNK) Passed With Ease
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Analyse-artikel • Mar 03
An Intrinsic Calculation For Cinemark Holdings, Inc. (NYSE:CNK) Suggests It's 23% Undervalued
Key Insights Cinemark Holdings' estimated fair value is US$33.14 based on 2 Stage Free Cash Flow to Equity Current...Seeking Alpha • Feb 20
Cinemark: Earnings Rebound Potential Lies In Popcorn
Summary Cinemark's Q4 results showed good growth as box office activity is returning from the Covid pandemic and Hollywood strike disruptions. The 2025 box office outlook remains good. Most of Cinemark's earnings rebound was made through high-margin concession sales, as popcorn and drinks are becoming even more critical for movie theaters' profitability. I estimate Cinemark's stock to be fairly valued at $33.5. Read the full article on Seeking AlphaAnalyse-artikel • Feb 04
Earnings Working Against Cinemark Holdings, Inc.'s (NYSE:CNK) Share Price
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...Analyse-artikel • Jan 20
Cinemark Holdings (NYSE:CNK) Has More To Do To Multiply In Value Going Forward
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...Analyse-artikel • Dec 24
Here's Why Cinemark Holdings (NYSE:CNK) Has A Meaningful Debt Burden
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2028 | 3,830 | 334 | 359 | 584 | 8 |
| 12/31/2027 | 3,673 | 305 | 317 | 545 | 10 |
| 12/31/2026 | 3,567 | 284 | 339 | 577 | 11 |
| 6/30/2026 | 3,363 | 214 | 313 | 579 | N/A |
| 3/31/2026 | 3,217 | 169 | 260 | 495 | N/A |
| 12/31/2025 | 3,115 | 137 | 177 | 396 | N/A |
| 9/30/2025 | 3,153 | 154 | 279 | 445 | N/A |
| 6/30/2025 | 3,217 | 289 | 305 | 461 | N/A |
| 3/31/2025 | 3,011 | 241 | 220 | 370 | N/A |
| 12/31/2024 | 3,050 | 304 | 315 | 466 | N/A |
| 9/30/2024 | 2,874 | 236 | 228 | 378 | N/A |
| 6/30/2024 | 2,827 | 140 | 213 | 355 | N/A |
| 3/31/2024 | 3,035 | 212 | 267 | 414 | N/A |
| 12/31/2023 | 3,067 | 185 | 295 | 444 | N/A |
| 9/30/2023 | 3,028 | 105 | 309 | 444 | N/A |
| 6/30/2023 | 2,803 | -8 | 216 | 341 | N/A |
| 3/31/2023 | 2,605 | -198 | 144 | 263 | N/A |
| 12/31/2022 | 2,455 | -267 | 25 | 136 | N/A |
| 9/30/2022 | 2,522 | -165 | 133 | 236 | N/A |
| 6/30/2022 | 2,306 | -217 | 130 | 234 | N/A |
| 3/31/2022 | 1,857 | -284 | 75 | 172 | N/A |
| 12/31/2021 | 1,511 | -417 | 71 | 166 | N/A |
| 9/30/2021 | 942 | -659 | -278 | -205 | N/A |
| 6/30/2021 | 543 | -729 | -267 | -198 | N/A |
| 3/31/2021 | 257 | -759 | -506 | -439 | N/A |
| 12/31/2020 | 686 | -613 | -414 | -330 | N/A |
| 9/30/2020 | 1,377 | -349 | -188 | -3 | N/A |
| 6/30/2020 | 2,163 | -171 | -131 | 105 | N/A |
| 3/31/2020 | 3,112 | 98 | N/A | 442 | N/A |
| 12/31/2019 | 3,283 | 190 | N/A | 562 | N/A |
| 9/30/2019 | 3,293 | 183 | N/A | 604 | N/A |
| 6/30/2019 | 3,225 | 202 | N/A | 581 | N/A |
| 3/31/2019 | 3,156 | 183 | N/A | 578 | N/A |
| 12/31/2018 | 3,222 | 213 | N/A | 557 | N/A |
| 9/30/2018 | 3,173 | 288 | N/A | 567 | N/A |
| 6/30/2018 | 3,130 | 276 | N/A | 573 | N/A |
| 3/31/2018 | 2,992 | 245 | N/A | 462 | N/A |
| 12/31/2017 | 2,992 | 263 | N/A | 529 | N/A |
| 9/30/2017 | 2,942 | 245 | N/A | 485 | N/A |
| 6/30/2017 | 3,000 | 272 | N/A | 487 | N/A |
| 3/31/2017 | 2,994 | 275 | N/A | 535 | N/A |
| 12/31/2016 | 2,919 | 254 | N/A | 463 | N/A |
| 9/30/2016 | 2,925 | 235 | N/A | 508 | N/A |
| 6/30/2016 | 2,857 | 215 | N/A | 476 | N/A |
| 3/31/2016 | 2,912 | 232 | N/A | 498 | N/A |
| 12/31/2015 | 2,853 | 216 | N/A | 456 | N/A |
| 9/30/2015 | 2,805 | 205 | N/A | 458 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei CNK ( 10.8% per jaar) ligt boven de spaarquote ( 3.7% ).
Winst versus markt: De winst van CNK ( 10.8% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 17.4% per jaar).
Hoge groeiwinsten: De winst van CNK zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van CNK ( 4.8% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 13.5% per jaar).
Hoge groei-inkomsten: De omzet van CNK ( 4.8% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen CNK zal naar verwachting over 3 jaar hoog zijn ( 39.1 %)
Ontdek groeibedrijven
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/09/18 17:09 |
| Aandelenkoers aan het einde van de dag | 2026/09/18 00:00 |
| Inkomsten | 2026/06/30 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Cinemark Holdings, Inc. wordt gevolgd door 26 analisten. 11 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| null null | Argus Research Company |
| Marla Backer | Ascendiant Capital Markets LLC |
| Anthony DiClemente | Barclays |